- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/16 - Animal cells
Patent holdings for IPC class C12N 5/16
Total number of patents in this class: 1303
10-year publication summary
|
56
|
78
|
85
|
92
|
69
|
60
|
53
|
46
|
38
|
14
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20015 |
19 |
| Regeneron Pharmaceuticals, Inc. | 4303 |
16 |
| F. Hoffmann-La Roche AG | 7939 |
14 |
| The Trustees of the University of Pennsylvania | 4328 |
13 |
| Amgen Inc. | 4093 |
12 |
| The Board of Trustees of the Leland Stanford Junior University | 6441 |
10 |
| Board of Regents, The University of Texas System | 5828 |
10 |
| The University of British Columbia | 1500 |
10 |
| Genentech, Inc. | 3979 |
9 |
| Abbvie Inc. | 1799 |
9 |
| CRISPR Therapeutics AG | 367 |
9 |
| Crystal Bioscience Inc. | 82 |
9 |
| Dana-Farber Cancer Institute, Inc. | 2574 |
9 |
| CHO Plus, Inc. | 14 |
8 |
| Novartis AG | 10727 |
7 |
| Centre National de La Recherche Scientifique | 10476 |
7 |
| The Trustees of Columbia University in the City of New York | 3580 |
7 |
| The Board of Trustees of the University of Illinois | 2704 |
7 |
| E. R. Squibb & Sons, L.L.C. | 119 |
7 |
| ImmunoGen, Inc. | 399 |
7 |
| Other owners | 1104 |